Medicine:ShuntCheck

From HandWiki
Short description: Diagnostic medical device
ShuntCheck
SCIII 4 PlaceTS and SCIII 12 PlaceIce.jpg
ShuntCheck Sensor & Ice Placement
UsesDetects flow in the cerebral shunts of hydrocephalus patients
ApproachNon-invasive

ShuntCheck is a non-invasive diagnostic medical device which detects flow in the cerebral shunts of hydrocephalus patients. Neurosurgeons can use ShuntCheck flow results along with other diagnostic tests to assess shunt function and malfunction.[1]

Hydrocephalus is a condition in which cerebrospinal fluid (CSF) accumulates in the brain, potentially leading to brain damage and death. It is corrected by a shunt which drains excess CSF from the brain to the abdomen. Shunts fail, typically by obstruction – a life-threatening medical condition requiring the surgical replacement of the shunt. The symptoms of shunt failure are non-specific – headache, nausea, lethargy – so diagnostic tests must be conducted to rule in or rule out surgery. Current methods of diagnosing shunt malfunction, including CT Scan, MRI, radionuclide studies and shunt tap, have limitations and risks. These limitations and risks led to the development of ShuntCheck.[2][3][4][5][6][7][8][9][10][11][12][13][excessive citations]

ShuntCheck uses thermal dilution[14][15] to detect flow. The ShuntCheck sensor, a high-tech skin thermometer, is placed over the shunt where it crosses the clavicle. The shunt, which lies just below the skin, is cooled with an ice pack placed “upstream” of the sensor. If CSF is flowing through the shunt, the cooled fluid will move “downstream” and the ShuntCheck sensor will detect a drop in temperature. Faster shunt flow results in greater temperature decreases. If the shunt is not flowing, the cooled fluid remains upstream and no temperature drop is recorded.[2]

The sensor is connected to a laptop or tablet computer running ShuntCheck software. The sensor is connected to a laptop or tablet computer running ShuntCheck software. The computer analyzes the thermal data, determines “Flow Confirmed” or “Flow NOT Confirmed” and presents a time-temperature graph.

ShuntCheck Results Screen

Early clinical testing of ShuntCheck found that functioning shunts flow intermittently, which meant that a ShuntCheck reading of “Flow NOT Confirmed” did not necessarily indicate a shunt problem.[2][16] This discovery led to the development of the ShuntCheck Micro-Pumper, a handheld device which vibrates the shunt valve, generating a temporary increase in flow through patent, but not through obstructed, shunts. Micro-Pumper allows ShuntCheck to differentiate between temporarily non-flowing patent shunts and obstructed shunts.[1]

Micro-Pumper

ShuntCheck III

The current version of ShuntCheck was developed in 2011-2012 funded by grants from the National Institute of Health[17][18][19] and was cleared by the US FDA in 2013.[1] The ShuntCheck system includes the ShuntCheck Sensor, a skin marker, an Instant Cold Pack, a Data Acquisition Unit (an analog-to-digital converter called the “DAQ”), a Windows 7 or Windows 8 laptop or tablet computer running ShuntCheck software and the Micro-Pumper.[1]

ShuntCheck System

ShuntCheck clinical studies

Boston Children's Hospital 2008-2009 Joseph R. Madsen MD tested 100 symptomatic and asymptomatic pediatric hydrocephalus patients using an earlier version of ShuntCheck during 2008–2009. His key findings, reported in Neurosurgery [2] were

  • The ShuntCheck test is sensitive and specific for detecting shunt flow
  • But failure to detect flow does not predict the need for surgery

University of South Florida 2008 Arthur E. Marlin MD and Sarah J Gaskill MD conducted ShuntCheck testing on 35 asymptomatic pediatric patients with similar results.[16]

These findings led to the development of the Micro-Pumper.

Boston Children's Hospital 2010-2013 Dr. Madsen is testing 130 symptomatic and asymptomatic pediatric hydrocephalus patients to assess the diagnostic accuracy and clinical utility of the newer version of ShuntCheck including Micro-Pumper. This study was funded by the NIH.[18][19]

Multi-Center Pediatric Outcomes Study 2013-2014 Boston Children's Hospital, Children's Hospital of Philadelphia, Johns Hopkins Hospital, Cleveland Clinic, University of Chicago Comer Children's Hospital, LeBonheur Children's Hospital and University of Texas Houston Children's Memorial Hermann Hospital will conduct an outcomes study of 400 symptomatic pediatric hydrocephalus patients during 2013–2014. In this NIH funded study,[19] ShuntCheck results and the results of standard of care diagnostic tests will be compared to clinical outcome (shunt obstruction confirmed by surgery vs no-obstruction). This study[20] seeks to demonstrate that

  • ShuntCheck is synergistic with imaging. Specifically that ShuntCheck plus imaging yield higher positive and negative predictive values than imaging alone.
  • ShuntCheck is comparable to imaging in ruling out shunt obstruction in cases which the Attending Physician judges to be “unlikely to require shunt surgery”.

Sinai Baltimore NPH Study 2012-2014 Michael A. Williams MD is conducting ShuntCheck testing on adult hydrocephalus patients undergoing radionuclide shunt patency testing. This study, funded by the NIH,[21][22] seeks to demonstrate that ShuntCheck results match radionuclide results.

Potential clinical uses of ShuntCheck

  1. A test for assessing shunt function in symptomatic hydrocephalus patients. ShuntCheck flow data, used in conjunction with other diagnostic test results and with physician judgment, can aid in ruling in or ruling out shunt obstruction.[1]
  2. A tool for establishing “normal” CSF flow patterns in asymptomatic patients. Establishing baseline flow may increase the value of flow information in symptomatic patients.[1]
  3. A tool to streamline the process of adjusting shunt valve settings to accommodate individual needs for CSF drainage. While the settings for these valves in each patient must currently be determined empirically over a number of weeks, Shuntcheck will be helpful in measuring changes in CSF flow due to changes in the valve setting.[23]
  4. A tool for assessing suspected over-drainage. CSF flow data will allow neurosurgeons to identify periods and causes of high CSF flow when assessing suspected CSF over drainage. This data can also be used to evaluate flow and siphon control devices to determine if they are meeting the patient's needs.
  5. A post operative test to confirm shunt function. Hospitals in sparsely populated areas often conduct post-surgical CT scans to confirm shunt function before releasing patients for the long drive home. CSF flow data can confirm shunt function more quickly than CT (which requires time for the ventricles to stabilize).

NeuroDx Development

NeuroDx Development [10] (NeuroDx) is an early commercial stage medical device company founded in 2008 by Fred Fritz (CEO), a serial life sciences entrepreneur, and Dr. Marek Swoboda (Chief Scientific Officer), a biosensor engineer, to address important unmet needs in the hydrocephalus market.[24] The company has developed two thermal dilution technologies for assessing shunt function in hydrocephalus patients, ShuntCheck-Micro-Pumper, an eight-minute test of CSF shunt flow, and Continuous Real Time (CRT) ShuntCheck, which uses thermal dilution to monitor changes in shunt flow over longer time periods.[25] The company's follow-on products, an implantable intracranial pressure monitoring device[26] and a non-invasive monitor of intracranial pressure, are in proof of concept development.

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "510(k) Summary". Accessdata.fda.gov. http://www.accessdata.fda.gov/cdrh_docs/pdf12/K123554.pdf. Retrieved 2013-10-14. 
  2. ↑ 2.0 2.1 2.2 2.3 Madsen JR, et al, Evaluation of the ShuntCheck Noninvasive Thermal Technique for Shunt Flow Detection in Hydrocephalic Patients, Neurosurgery 68:198-205, 2011
  3. ↑ Brenner DJ, Hall EJ, Computed Tomography – An Increasing Source of Radiation Exposure, N Engl J Med 2007;357:2277-84
  4. ↑ Iskandar, B., et al., Pitfalls in the diagnosis of ventricular shunt dysfunction: radiology reports and ventricular size. Pediatrics, 1998. 101: p. 1031-1036.
  5. ↑ Forrest, D. and D. Cooper, Complications of ventriculo-atrial shunts. J Neurosurg, 1968. 29: p. 506-512.
  6. ↑ Iskandar, B., et al., Death in shunted hydrocephalic children in the 1990s. Pediatr Neurosurg, 1998. 28: p. 173-176.
  7. ↑ Piatt, J., Physical examination of patients with cerebrospinal fluid shunt: is there useful information in pumping the shunt? Pediatrics, 1992. 89: p. 470-473.
  8. ↑ Noetzel, M. and R. Baker, Shunt fluid evaluation: risks and benefits in the evaluation of shunt malfunction and infection. J Neurosurg, 1984. 61: p. 328-332.
  9. ↑ Howman-Giles, R., et al., A radionuclide method of evaluating shunt function and CSF circulation in hydrocephalus. J Neurosurg, 1984. 61: p. 604-605.
  10. ↑ Vernet, O., et al., Radionuclide shuntogram; adjunct to manage hydrocephalic patients. J Nucl Med, 1996. 37: p. 406-410.
  11. ↑ Brendel, A., et al., Cerebrospinal shunt flow in adults: radionuclide quantitation with emphasis on patient position. Radiology, 1983. 149: p. 815-818.
  12. ↑ Pitteti R. 2007. Emergency department evaluation of ventricular shunt malfunction: is the shunt series really necessary? Pediatr. Emerg. Care 23: 137-141.
  13. ↑ Sood S, Canady AI, Harn, SD. 2000. Evaluation of shunt malfunction using shunt site reservoir. Pediatr. Neurosurg. 32: 180-186.
  14. ↑ Stein SC, Apfel S, A noninvasive approach to quantitative measurement of flow through CSF shunts. Technical note, J Neurosurg 1981 Apr,54(4):556-8
  15. ↑ Neff S, Measurement of flow in cerebrospinal fluid in shunts by transcutaneous thermal convection, J Neurosurg (Pediatrics 4) 103:366-373, 2005
  16. ↑ 16.0 16.1 Marlin AE, Gaskill SJ, The Use of Transcutaneous Thermal Convection Analysis to Assess Shunt Function in the Pediatric Population, Neurosurgery 70:181-3, 2012
  17. ↑ "TAGGS Award Detail". Taggs.hhs.gov. 2009-09-01. http://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R43NS067772&n_Prog_Office_Code=137. Retrieved 2013-10-14. 
  18. ↑ 18.0 18.1 "TAGGS Award Detail". Taggs.hhs.gov. 2009-09-01. http://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R43HD065429&n_Prog_Office_Code=50. Retrieved 2013-10-14. 
  19. ↑ 19.0 19.1 19.2 "TAGGS Award Detail". Taggs.hhs.gov. 2009-09-01. http://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R44NS067772&n_Prog_Office_Code=137. Retrieved 2013-10-14. 
  20. ↑ "ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study - Full Text View". ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01881711?term=shuntcheck&rank=4. Retrieved 2013-10-14. 
  21. ↑ "TAGGS Award Detail". Taggs.hhs.gov. 2009-09-01. http://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R43NS067770&n_Prog_Office_Code=137. Retrieved 2013-10-14. 
  22. ↑ "ShuntCheck Versus Radionuclide in Evaluating Shunt Function in Symptomatic NPH Patients - Full Text View". ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01323764?term=shuntcheck&rank=1. Retrieved 2013-10-14. 
  23. ↑ "ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients - Full Text View". ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT00793416?term=shuntcheck&rank=2. Retrieved 2013-10-14. 
  24. ↑ "NeuroDx Development". Neurodx.com. http://www.neurodx.com. Retrieved 2013-10-14. 
  25. ↑ "TAGGS Award Detail". Taggs.hhs.gov. 2009-09-01. http://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R44NS074486&n_Prog_Office_Code=137. Retrieved 2013-10-14. 
  26. ↑ "TAGGS Award Detail". Taggs.hhs.gov. 2009-09-01. http://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R43NS077523&n_Prog_Office_Code=137. Retrieved 2013-10-14. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:ShuntCheck&oldid=3273013"